Höffken K, Price M R, McLaughlin P J, Moore V E, Baldwin R W
Int J Cancer. 1978 Apr 15;21(4):496-504. doi: 10.1002/ijc.2910210416.
Circulating immune complexes were measured in sequential monitoring studies in rats bearing chemically induced tumours at different body sites. The assay employed were based upon radioimmunoprecipitation of serum factors with 125I-C1q or with an indirect test whereby the inhibition of binding of 125I-C1q to IgG aggregates by tumour-bearer sera was measured. 125I-C1q-binding immune complexes were detected at the initial phase of tumour growth and the level of this activity returned to the normal range after tumour excision. With tumour growing at subcutaneous sites or in th peritoneal cavity, serum-borne C1q-binding material, after reaching a maximum level, decreased despite tumour progression and eventually fell into sub-normal ranges at terminal stages of growth. In contrast, following intravenous tumour cell injection, immune-complex levels increased until terminal stages of disease. The present findings indicate that the measurement of C1q-binding serum factors represents a useful method for monitoring the growth and burden of experimental animal tumours.
在对不同身体部位患有化学诱导肿瘤的大鼠进行的连续监测研究中,对循环免疫复合物进行了测量。所采用的检测方法基于用125I-C1q对血清因子进行放射免疫沉淀,或基于一种间接检测方法,即测量荷瘤血清对125I-C1q与IgG聚集体结合的抑制作用。在肿瘤生长的初始阶段检测到125I-C1q结合免疫复合物,肿瘤切除后该活性水平恢复到正常范围。当肿瘤在皮下部位或腹腔内生长时,血清中C1q结合物质在达到最高水平后,尽管肿瘤继续进展,但仍会下降,最终在生长末期降至正常范围以下。相比之下,静脉注射肿瘤细胞后,免疫复合物水平会一直升高直至疾病末期。目前的研究结果表明,测量C1q结合血清因子是监测实验动物肿瘤生长和负荷的一种有用方法。